Skip to main content
SLDB logo

SLDB · Solid Biosciences Inc. · Holdings

Track SLDB — free
$6.25 -0.19 (-2.95%) At close · Nov 20 Q1 2022 earnings call transcript
Market Cap
$697.57M
Shares
111.61M
Volume · Nov 20 1.56M Avg daily vol (3M) 1.29M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 158
Total Value: $859,767,062
Total Shares: 118,916,621
Showing 1–100 of 162 holdings by value · page 1 of 2

Institutional Ownership Trend

27 quarters

Holder Concentration

Share of 13F common-share value, across 158 filers with any position, options included · Δ vs Jun 30, 2026
Top Holder
10.1%
Dec 2023 → Sep 2026 · range 10.1% – 21.0%
−0.4 pts
Top 5
41.0%
Dec 2023 → Sep 2026 · range 41.0% – 74.7%
−1.3 pts
Top 10
62.3%
Dec 2023 → Sep 2026 · range 62.3% – 95.1%
−0.3 pts
HHI
501
Dec 2023 → Sep 2026 · range 501 – 1,419
Broadly held−23

Who Holds SLDB

Last 8 quarters through Sep 30, 2026

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Sep 30, 2026: 158 filers, like-for-like change +5.1%; actively managed books +6.9%; index-like books -2.7%.

Holder type Share Filers Change
Registered adviser 50.5% 85 +3.8%
Exempt adviser 1.0% 4 +341.9%
Adviser 11.7% 7 +17.3%
Bank 5.3% 13 -1.1%
Insurer 0.0% 2 +84.4%
Broker-dealer 0.1% 3 +784.3%
Benefit plan 0.0% 2 -43.5%
Non-US 0.1% 4 -36.6%
Holding company 14.1% 7 +5.3%
Unknown 17.1% 31 +0.3%
How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Excluded 1 holder with no observed 2026-06-30 13F and 3 holders with no observed 2026-09-30 13F.

Conviction and Crowding

158 13F filers, quarter ended Sep 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
3
1.90% of filers hold it in their top 10
Jun 30, 2026: 3
Holders above 5%
1
median weight 0.001%
Jun 30, 2026: 2
Crowding
—
holders exceed shares outstanding: 13F filers report more shares than the cover-page count, which predates an issuance, is misstated, or misses shares lent and reported twice
Private-fund advisers
—
of shares outstanding
Institutional ownership
—
holders exceed shares outstanding: 13F filers report more shares than the cover-page count, which predates an issuance, is misstated, or misses shares lent and reported twice
Top 10 holders
62.3%
of 13F shares, Herfindahl 0.050
Active holders
+6.9%
like-for-like share change of active filers
5% stakes on record
8
2 13D, 6 13G (3 institutional, 3 passive, 0 exempt)
How long holders have held it value-weighted 14.1 quarters
Under 1 year 22.8% 1 to 3 years 36.2% 3 years or more 41.0% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net buyers of $16,288,834 (6 buying, 8 selling).

Estimated Holder Cost Basis

Quarter ended Sep 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$6.71
estimated per share
Jun 30, 2026: $6.21
Quarter-end price
$7.23
implied by 13F values
Estimated gain or loss
+7.7%
price against the estimated cost
Estimated at a loss
24.8%
of costed 13F value

Estimated cost covers 42.5% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies SLDB's active holders also own, quarter ended Sep 30, 2026
# Company Shared holders
1 IVVD Invivyd, Inc. 7
2 RZLT Rezolute, Inc. 6
3 COAG Hemab Therapeutics Holdings, Inc. 5
4 CGEM Cullinan Therapeutics, Inc. 6
5 OLMA Olema Oncology, Inc. 6
6 VYGR Voyager Therapeutics, Inc. 3
7 YARW Yarrow Bioscience, Inc. 5
8 BLSM BlossomHill Therapeutics, Inc. 4
9 STOK Stoke Therapeutics, Inc. 6
10 PALI Palisade Bio, Inc. 6

Shareholder Targets

13F filers that own its peers but not SLDB, quarter ended Sep 30, 2026

Found through its holder-overlap peers: IVVD, RZLT, COAG, CGEM, OLMA, VYGR, YARW, BLSM, STOK, PALI, IMVT, IRON, SLN, KLRA, MGNX, PRLD, ORKA, ADRX, RACD, XENE. 498 filers in all.

# Filer In peers
1 ORBIMED ADVISORS LLC Registered adviser, Diversified active $592,917,875 4 held
2 Venrock Adviser, LLC Registered adviser, Concentrated $402,723,342 4 held
3 TCG Crossover Management, LLC Unknown, Diversified active $350,237,389 6 held
4 Capital World Investors Adviser, Diversified active $329,266,098 3 held
5 Polar Capital Holdings Plc Registered adviser, Diversified active $310,397,637 3 held
6 Fairmount Funds Management LLC Registered adviser, Concentrated $308,611,271 1 held
7 Paradigm Biocapital Advisors LP Registered adviser, Concentrated $302,439,035 3 held
8 Bain Capital Investors LLC Unknown, Concentrated $299,838,735 1 held
9 BVF INC/IL Unknown, Concentrated $273,640,851 6 held
10 Avoro Capital Advisors LLC Registered adviser, Concentrated $262,905,752 2 held

Fund Ownership of SLDB by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 11.90% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.11% 2,356,437
Index ETFs 9.79% 10,922,061
Active ETFs 0.72% 802,599
Active funds 5.17% 5,766,770
Unclassified 1.34% 1,500,394
All registered funds 19.13% 21,348,261
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Quarterly Activity

vs Jun 30, 2026
New
25
Increased
57
Decreased
45
Sold Out
21
Unchanged
30

New and Sold Out count only filers that reported a 13F for both quarters: a first-time filer's book is not a buy, and a fund that has not filed, or withheld its positions under confidential treatment, has not sold.

Holder count: +2
Institutional value: -24.9%
Shares held: +3.8%

Top Buyers

vs Jun 30, 2026
Institution Added Now Holds Open

Top Sellers

vs Jun 30, 2026
Institution Sold Now Holds Open

Top New Positions

vs Jun 30, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Jun 30, 2026
Institution Previously Held Last Value (USD) Open
Showing 100 of 162
Export CSV
Holder Value (USD) % of 13F Shares Own % Change Type Filed Open

Showing the top 100 of 162 holders. Create a free account to see every holder, past quarters, search, filters and CSV export.

Key facts CIK 1707502 CUSIP 83422E204 13F (30d) 160 filings 144 filers Visit website Investor relations